“I am pleased to report another strong set of results covering the first half of our financial year. Underlying revenue growth was 18% and the EBITDA margin was in line with our guidance. I’d like to thank all Dr. Martens people for their hard work and custodianship over the last six months in helping to deliver these results.

“Our growth is built on the successful execution of our DOCS strategy, led by the DTC-first approach, with DTC revenue up 21%. At the heart of our continued success is the strength of our brand, highlighted by underlying pairs growth and continually improving brand metrics. We have further pricing headroom for AW23 so we will offset cost inflation once again.

“Although there are economic challenges ahead, we are well positioned for future growth. We will continue to drive growth investment to deliver the DOCS strategy, mainly in new stores, marketing, people, technology and inventory. Reflecting our confidence in the future, our balanced global revenues and our strong balance sheet, the board has decided to increase the interim dividend by 28% to 1.56p per share.”

Kenny Wilson, Chief Executive Officer

Kenny Wilson, CEO

Reports and publications archive

Date 24 Nov 2022
Title FY23 H1 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read
Date 14 Jul 2022
Title AGM Trading Update
Statement View(Statement)
Date 06 Jul 2022
Title Conversion Markets Teach-In
Presentation View
Webcast Watch
Read
Date 14 Jun 2022
Title FY22 Annual Report
Report View
View ESEF XHTML
Download ESEF ZIP
Date 14 Jun 2022
Title 2022 AGM Notice of Meeting
Report View
Date 01 Jun 2022
Title FY22 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read
Link Visit
Date 27 Jan 2022
Title FY22 Q3 Trading Statement
Statement View(Statement)
Webcast Watch
Read
Date 09 Dec 2021
Title FY22 H1 Results
Presentation View
Statement View(Statement)
Webcast Watch
Read
Date 29 Jul 2021
Title FY22 Q1 Trading Statement
Statement View(Statement)
Date 01 Jul 2021
Title 2021 AGM Notice of Meeting
Report View
Date 01 Jul 2021
Title FY21 Annual Report
Report View
Date 17 Jun 2021
Title FY21 results
Presentation View
Statement View(Statement)
Webcast Watch
Read